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Purpose
The eyedrop form of rebamipide was approved in Japan
for use in the treatment of dry eye diseases, because it
up-regulates mucin secretion and production. Others
reported that rebamipide, a gastroprotective drug, could
not only increase gastric mucus production but also
suppressed gastric mucosal inflammation and that it was
dominantly distributed in mucosal tissues. In this study
we investigated whether rebamipide has anti- inflamma-
tory effects in the ocular surface.
Methods
We used ELISA and quantitative RT-PCR assay to
examine the effects of rebamipide on polyI:C-induced
cytokine expression by primary human conjunctival
epithelial cells. We studied the effects of rebamipide on
ocular surface inflammation in our murine experimental
allergic conjunctivitis (EAC) model. Moreover, we also
observed their condition of allergic conjunctivitis when
we treated the dry eye patients accompanied with aller-
gic conjunctivitis using rebamipide.
Results
Rebamipide could suppress polyI:C-induced cytokine
mRNA expression and the production of CXCL10,
CXCL11, RANTES, MCP-1, and IL-6 in human con-
junctival epithelial cells. The topical administration of
rebamipide suppressed conjunctival allergic eosinophil
infiltration in our EAC model. Furthermore, the allergic
conjunctivitis which accompanied by dry eye patients
treated with rebamipide tended to be better.
Conclusions
The topical application of rebamipide on the ocular
surface might suppress ocular surface inflammation
by suppressing the production of cytokines by ocular
surface epithelial cells.
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